We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Good vascular access continues to be a ...

Intravascular catheter-related bloodstream infections are a major cause of morbidity and mortality in the United States. In the intensive care unit (ICU), the rate of central venous catheter ...

Patients undergoing bone marrow transplantation require long-term venous access for the administration of medication, blood products, parenteral hyperalimentation and for blood sampling. Central ...

A catheter dressing incorporating a chlorhexidine gluconate gel pad may reduce the presence of microorganisms at insertion and suture sites, according to recently published data. “The use of [central ...

DefenCath is intended for instillation into central venous catheters only. DefenCath ® (taurolidine and heparin) catheter lock solution is now available for inpatient use to reduce the incidence of ...

Signs and symptoms of CRBSI are nonspecific. Fever is the most common clinical sign of CRBSI and all febrile episodes in children with CVCs must be investigated for CRBSI. Particular attention should ...

In this prospective study, we assessed the incidence of central venous catheter (CVC)-related thrombosis in haematopoietic stem cell transplant (HSCT) recipients. We determined the contribution of ...

The cumulative incidence of CVC-related infection was 24% (25 of 105 patients). Clinically manifest thrombosis occurred in 13 (12%) of 105 patients. In patients with CVC-related infection, the risk of ...

S&S Insider reported that the U.S. central venous catheter market is projected to hit USD 1.09 billion by 2032 as demand for oncology, dialysis, and ICU procedures accelerates.Austin, Sept. 30, 2025 ...